[144] Sight Sciences, Inc. SEC Filing
Sight Sciences, Inc. (SGHT) Form 144 filing reports a proposed sale of 24,441 common shares through Fidelity Brokerage Services LLC on Nasdaq. The shares were acquired by restricted stock vesting on 09/30/2025 and are identified as compensation. The filer reports 52,367,359 shares outstanding for the class, and records an approximate aggregate market value of $81,740.48 for the shares to be sold with an approximate sale date of 10/01/2025. The filing also discloses that Paul Badawi sold 23,637 common shares on 07/01/2025 for gross proceeds of $98,133.73. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Form 144 di Sight Sciences, Inc. (SGHT) segnala una proposta di vendita di 24.441 azioni ordinarie tramite Fidelity Brokerage Services LLC su Nasdaq. Le azioni sono state acquisite mediante vesting di azioni soggette a restrizioni il 30/09/2025 e sono indicate come compenso. Il dichiarante riporta 52.367.359 azioni in circolazione per la classe e stima un valore di mercato aggregato approssimativo di 81.740,48 USD per le azioni da vendere, con una data di vendita approssimativa del 01/10/2025. La presentazione segnala inoltre che Paul Badawi ha venduto 23.637 azioni ordinarie il 01/07/2025 per proventi lordi di 98.133,73 USD. L’avviso include la dichiarazione standard secondo cui il venditore non è a conoscenza di informazioni materiali avverse non divulgate sull’emittente.
Sight Sciences, Inc. (SGHT) Formulario 144 presenta una propuesta de venta de 24,441 acciones comunes a través de Fidelity Brokerage Services LLC en Nasdaq. Las acciones fueron adquiridas mediante vesting de acciones restringidas el 30/09/2025 y se identifican como compensación. El presentante reporta 52,367,359 acciones en circulación para la clase y registra un valor de mercado agregado aproximado de $81,740.48 para las acciones a vender con una fecha de venta aproximada del 01/10/2025. La presentación también revela que Paul Badawi vendió 23,637 acciones comunes el 01/07/2025 por ingresos brutos de $98,133.73. El aviso incluye la declaración estándar de que el vendedor no está al tanto de información adversa material no revelada sobre el emisor.
Sight Sciences, Inc. (SGHT) Form 144 제출은 나스닥에서 Fidelity Brokerage Services LLC를 통해 24,441주 보통주 매각을 제안합니다. 해당 주식은 2025년 9월 30일에 제한 주식의 베스팅으로 취득되었으며 보상으로 식별됩니다. 신고인은 해당 클래스의 유통 주식 수를 52,367,359주로 보고하고 매각될 주식의 합산 시가를 대략 81,740.48달러로 기록하며 대략적인 매각 날짜를 2025년 10월 1일로 제시합니다. 또한 Paul Badawi가 2025년 7월 1일에 23,637주를 매도하여 총수익이 98,133.73달러였다고 공시합니다. 공지는 발행사에 관한 비공개 유의한 악재 정보에 대해 매도자가 인지하고 있지 않다는 표준 진술을 포함합니다.
Sight Sciences, Inc. (SGHT) Formulaire 144 signale une proposition de vente de 24 441 actions ordinaires par Fidelity Brokerage Services LLC sur Nasdaq. Les actions ont été acquises par vesting d'actions restreintes le 30/09/2025 et sont identifiées comme compensation. Le déclarant indique 52 367 359 actions en circulation pour la catégorie et enregistre une valeur marchande brute approximative de 81 740,48 $ pour les actions à vendre, avec une date de vente approximative du 01/10/2025. Le dossier divulgue également que Paul Badawi a vendu 23 637 actions ordinaires le 01/07/2025 pour des produits bruts de 98 133,73 $. L’avis comprend la déclaration standard selon laquelle le vendeur n’est pas au courant d’informations défavorables matérielles non divulguées concernant l’émetteur.
Sight Sciences, Inc. (SGHT) Form 144-Anmeldung meldet den vorgeschlagenen Verkauf von 24.441 Stammaktien über Fidelity Brokerage Services LLC an Nasdaq. Die Aktien wurden am 30.09.2025 durch Vesting eingeschränkter Aktien erworben und werden als Vergütung ausgewiesen. Der Einreicher meldet 52.367.359 ausstehende Aktien der Klasse und vermerkt einen ungefähren Brutto-Marktwert von 81.740,48 USD für die zu verkaufenden Aktien bei einem ungefähren Verkaufsdatum vom 01.10.2025. Die Einreichung gibt außerdem bekannt, dass Paul Badawi am 01.07.2025 23.637 Stammaktien zu Bruttoerlösen von 98.133,73 USD verkauft hat. Die Mitteilung enthält die Standarderklärung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten kennt.
تقرير Form 144 من Sight Sciences, Inc. (SGHT) يعلن عن اقتراح بيع 24,441 سهماً عاديًا من خلال Fidelity Brokerage Services LLC في ناسداك. تم الحصول على الأسهم عن طريق استحقاق الأسهم المقيدة في 30/09/2025 وتُعرّف كتعويض. يفيد المقدم بأن هناك 52,367,359 سهماً قائماً للصنف، ويسجل قيمة سوقية إجمالية تقريبية قدرها 81,740.48 دولار أمريكي للأسهم المراد بيعها مع تاريخ بيع تقريبي في 01/10/2025. كما يكشف الإقرار أن Paul Badawi باع 23,637 سهماً عاديًا في 01/07/2025 مقابل عوائد إجمالية قدرها 98,133.73 دولار. يتضمن الإشعار أيضًا البيان القياسي بأن البائع غير مدرك لوجود معلومات سلبية جوهرية غير مُعلنة عن المصدر.
Sight Sciences, Inc.(SGHT) Form 144 披露了通过 Fidelity Brokerage Services LLC 在纳斯达克拟出售 24,441 股普通股。 这些股票通过受限股权在 2025/09/30 完成归属,被识别为报酬。申报人报告该类股票的流通股数为 52,367,359 股,并记录拟出售股票的近似总市值为 81,740.48 美元,拟售日期近似为 2025/10/01。申报还披露 Paul Badawi 于 2025/07/01 出售了 23,637 股普通股,毛收入为 98,133.73 美元。通知还包含标准声明,即卖方并不知情有关发行人的未披露重要不利信息。
- Disclosure compliance: The filing provides required Rule 144 information including broker, share count, acquisition method, and attestation.
- Source of shares specified: The 24,441 shares are identified as resulting from restricted stock vesting and payment characterized as compensation.
- Insider sales disclosed: A recent sale of 23,637 shares by Paul Badawi on 07/01/2025 for $98,133.73 is disclosed, indicating insider liquidity activity.
- Limited context: The filing contains transaction details but provides no explanation of the seller’s intent or broader executive ownership changes.
Insights
TL;DR: A routine insider sale notice for a modest number of vested shares, with a recent separate insider sale also disclosed.
The filing documents a Rule 144 notice for 24,441 vested restricted shares to be sold through a broker on Nasdaq and reports the total shares outstanding for the class. The disclosure of a prior sale by Paul Badawi (23,637 shares) provides recent insider liquidity context. There are no financial results, forward guidance, or material new corporate events disclosed in this notice, so its immediate market impact is likely limited. Investors should view this as a compliance filing documenting intended sales under Rule 144 rather than a corporate development.
TL;DR: The filing is a standard compliance disclosure; it confirms compensation-based vesting and subsequent planned resale under Rule 144.
The document states the 24,441 shares arise from restricted stock vesting and that payment was characterized as compensation. The seller’s attestation regarding material information is present, consistent with Rule 144 requirements. The separate entry showing a recent sale by Paul Badawi signals insider selling activity but without accompanying context on intent or frequency. From a governance perspective, the filing meets disclosure norms but does not provide additional insights into executive ownership changes or retention trends beyond the transactions listed.
Form 144 di Sight Sciences, Inc. (SGHT) segnala una proposta di vendita di 24.441 azioni ordinarie tramite Fidelity Brokerage Services LLC su Nasdaq. Le azioni sono state acquisite mediante vesting di azioni soggette a restrizioni il 30/09/2025 e sono indicate come compenso. Il dichiarante riporta 52.367.359 azioni in circolazione per la classe e stima un valore di mercato aggregato approssimativo di 81.740,48 USD per le azioni da vendere, con una data di vendita approssimativa del 01/10/2025. La presentazione segnala inoltre che Paul Badawi ha venduto 23.637 azioni ordinarie il 01/07/2025 per proventi lordi di 98.133,73 USD. L’avviso include la dichiarazione standard secondo cui il venditore non è a conoscenza di informazioni materiali avverse non divulgate sull’emittente.
Sight Sciences, Inc. (SGHT) Formulario 144 presenta una propuesta de venta de 24,441 acciones comunes a través de Fidelity Brokerage Services LLC en Nasdaq. Las acciones fueron adquiridas mediante vesting de acciones restringidas el 30/09/2025 y se identifican como compensación. El presentante reporta 52,367,359 acciones en circulación para la clase y registra un valor de mercado agregado aproximado de $81,740.48 para las acciones a vender con una fecha de venta aproximada del 01/10/2025. La presentación también revela que Paul Badawi vendió 23,637 acciones comunes el 01/07/2025 por ingresos brutos de $98,133.73. El aviso incluye la declaración estándar de que el vendedor no está al tanto de información adversa material no revelada sobre el emisor.
Sight Sciences, Inc. (SGHT) Form 144 제출은 나스닥에서 Fidelity Brokerage Services LLC를 통해 24,441주 보통주 매각을 제안합니다. 해당 주식은 2025년 9월 30일에 제한 주식의 베스팅으로 취득되었으며 보상으로 식별됩니다. 신고인은 해당 클래스의 유통 주식 수를 52,367,359주로 보고하고 매각될 주식의 합산 시가를 대략 81,740.48달러로 기록하며 대략적인 매각 날짜를 2025년 10월 1일로 제시합니다. 또한 Paul Badawi가 2025년 7월 1일에 23,637주를 매도하여 총수익이 98,133.73달러였다고 공시합니다. 공지는 발행사에 관한 비공개 유의한 악재 정보에 대해 매도자가 인지하고 있지 않다는 표준 진술을 포함합니다.
Sight Sciences, Inc. (SGHT) Formulaire 144 signale une proposition de vente de 24 441 actions ordinaires par Fidelity Brokerage Services LLC sur Nasdaq. Les actions ont été acquises par vesting d'actions restreintes le 30/09/2025 et sont identifiées comme compensation. Le déclarant indique 52 367 359 actions en circulation pour la catégorie et enregistre une valeur marchande brute approximative de 81 740,48 $ pour les actions à vendre, avec une date de vente approximative du 01/10/2025. Le dossier divulgue également que Paul Badawi a vendu 23 637 actions ordinaires le 01/07/2025 pour des produits bruts de 98 133,73 $. L’avis comprend la déclaration standard selon laquelle le vendeur n’est pas au courant d’informations défavorables matérielles non divulguées concernant l’émetteur.
Sight Sciences, Inc. (SGHT) Form 144-Anmeldung meldet den vorgeschlagenen Verkauf von 24.441 Stammaktien über Fidelity Brokerage Services LLC an Nasdaq. Die Aktien wurden am 30.09.2025 durch Vesting eingeschränkter Aktien erworben und werden als Vergütung ausgewiesen. Der Einreicher meldet 52.367.359 ausstehende Aktien der Klasse und vermerkt einen ungefähren Brutto-Marktwert von 81.740,48 USD für die zu verkaufenden Aktien bei einem ungefähren Verkaufsdatum vom 01.10.2025. Die Einreichung gibt außerdem bekannt, dass Paul Badawi am 01.07.2025 23.637 Stammaktien zu Bruttoerlösen von 98.133,73 USD verkauft hat. Die Mitteilung enthält die Standarderklärung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten kennt.